FDA, Hospitals and Process Improvement - Pharmacy Technician Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

FDA

Hospitals

Process Improvement

Developing a first-in-class small molecule drug for inflammatory disease

European Pharmaceutical Review

NOVEMBER 9, 2023

MyMD plans to present the data to the US Food and Drug Administration (FDA) and intends to advance the clinical programme for MYMD-1 into Phase III either alone or through partnership. There are no FDA-approved medications to treat sarcopenia. Why is a TNF-α inhibitor promising as a first-in-class therapeutic for sarcopenia/frailty?

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Immunization Process Improvement

Considerations for a Decentralized Manufacturing Paradigm

ISPE

SEPTEMBER 11, 2023

FDA Official Warns Manufacturers of Common Problems Found in Aseptic Operations.” www.raps.org/news-and-articles/news-articles/2023/3/fda-official-warns-manufacturers-of-common-problem 25 US Food and Drug Administration Center for Drug Evaluation and Research. September 2022. 25%20from%202022%20to%202027 24 Eglovitch, J. 7 March 2023.

Health and Personal Care Stores

Health and Personal Care Stores Vaccines Packaging Documentation

Developing a first-in-class small molecule drug for inflammatory disease

Considerations for a Decentralized Manufacturing Paradigm

Stay Connected